Fent, Genevieve M.
Despa, Simona
Gabor, Les
Earll, Madison
McCandless, Erin E.
O’Kelley, Sandra
Patch, Jared R.
Snyder, Jonathan
King, Stephen
Funding for this research was provided by:
Elanco Animal Health
Article History
Received: 24 September 2024
Accepted: 23 June 2025
First Online: 14 July 2025
Declarations
:
: The animal phase of this study was conducted in accordance with Good Laboratory Practice (GLP) and was reviewed and approved by the study site Institutional Animal Care and Use Committee. It was executed in compliance with the US Code of Federal Regulations Title 9, Parts 1–4, The Animal Welfare Regulations; US Code of Federal Regulations Title 7, Chap. 54, Sects. 2131–2159, The Animal Welfare Act and followed the Guide for the Care and Use of Laboratory Animals. The molecular diagnostics described herein were not conducted as part of the original animal study. Molecular diagnostic tests were developed and conducted non-GLP in the laboratory on FFPE tissue generated during the study live-phase.
: Not applicable.
: Genevieve M. Fent, Simona Despa, Les Gabor, Madison Earll, Sandra O’Kelley, Jared R. Patch, Jonathan Snyder, and Stephen King are current or former employees of Elanco Animal Health.